Sandra E. Pierce
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Penske Automotive Named in Q3 Consumer Stock Watchlist. Benzinga included Penske Automotive Group in a list of top consumer stocks that may see gains in the third quarter. The company is currently trading near its 52-week high, with an average analyst target of $212.14. This inclusion highlights continued interest in the auto retail sector despite mixed technical signals.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HBAN Earnings Outlook and Valuation Concerns Highlighted. Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.
Transaction History
| DCH | ▲ Buy | Grant | 29,773 | $0 | 4/30/2026 | View on chart |
| PAG | ▲ Buy | Grant | 1,488 | $0 | 12/16/2025 | View on chart |
| PAG | ▼ Sell | Open Market | 1,604 | $300K | 8/29/2025 | View on chart |
| DCH | ▲ Buy | Grant | 39,474 | $150K | 5/1/2025 | View on chart |
| PAG | ▲ Buy | Grant | 1,529 | $0 | 12/11/2024 | View on chart |
| DCH | ▲ Buy | Grant | 20,492 | $150K | 5/2/2024 | View on chart |
| PAG | ▲ Buy | Grant | 1,604 | $0 | 12/13/2023 | View on chart |
| PAG | ▼ Sell | Open Market | 8,750 | $1.3M | 12/11/2023 | View on chart |
| DCH | ▲ Buy | Grant | 20,030 | $0 | 5/4/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 145,506 | $0 | 5/1/2023 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 769 | $8K | 5/1/2023 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 1,305 | $14K | 5/1/2023 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 9,394 | $103K | 5/1/2023 | View on chart |
| HBAN | ▲ Buy | Grant | 49,019 | $0 | 3/1/2023 | View on chart |
| PAG | ▼ Sell | Open Market | 3,417 | $397K | 6/2/2022 | View on chart |
| PAG | ▼ Sell | Open Market | 400 | $46K | 6/2/2022 | View on chart |
| DCH | ▲ Buy | Grant | 19,095 | $0 | 5/5/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 68,041 | $0 | 5/1/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 735 | $10K | 5/1/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 789 | $10K | 5/1/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 4,406 | $58K | 5/1/2022 | View on chart |
| HBAN | ▲ Buy | Grant | 52,119 | $0 | 3/1/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 1,400 | $22K | 2/28/2022 | View on chart |
| HBAN | ▼ Sell | Open Market | 17,511 | $304K | 1/10/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 16,367 | $278K | 1/7/2022 | View on chart |
| HBAN | ▼ Sell | Tax Withholding | 16,797 | $286K | 1/7/2022 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 25,338 | $217K | 1/7/2022 | View on chart |
| HBAN | ▲ Buy | Option Exercise | 25,337 | $217K | 1/7/2022 | View on chart |
| HBAN | ▼ Sell | Open Market | 19,815 | $336K | 1/6/2022 | View on chart |
| PAG | ▲ Buy | Grant | 2,477 | $0 | 12/16/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Dauch names new CFO, faces lower price targets from Barclays and UBS
Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.
Dauch names new CFO, faces lower price targets from Barclays and UBS. Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.